William G. Nelson
William G. Nelson
Professor of Oncology, Johns Hopkins University School of Medicine
Verified email at
Cited by
Cited by
Inflammation in prostate carcinogenesis
AM De Marzo, EA Platz, S Sutcliffe, J Xu, H Grönberg, CG Drake, Y Nakai, ...
Nature Reviews Cancer 7 (4), 256-269, 2007
DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways
WG Nelson, MB Kastan
Molecular and cellular biology 14 (3), 1815-1823, 1994
Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis
AM De Marzo, VL Marchi, JI Epstein, WG Nelson
The American journal of pathology 155 (6), 1985-1992, 1999
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis
WH Lee, RA Morton, JI Epstein, JD Brooks, PA Campbell, GS Bova, ...
Proceedings of the National Academy of Sciences 91 (24), 11733-11737, 1994
Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies.
J Woodcock-Mitchell, R Eichner, WG Nelson, TT Sun
The Journal of cell biology 95 (2), 580-588, 1982
Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies
SCG Tseng, MJ Jarvinen, WG Nelson, JW Huang, J Woodcock-Mitchell, ...
Cell 30 (2), 361-372, 1982
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
W Liu, S Laitinen, S Khan, M Vihinen, J Kowalski, G Yu, L Chen, ...
Nature medicine 15 (5), 559-565, 2009
Pathological and molecular aspects of prostate cancer
AM DeMarzo, WG Nelson, WB Isaacs, JI Epstein
The Lancet 361 (9361), 955-964, 2003
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
TD Kessis, RJ Slebos, WG Nelson, MB Kastan, BS Plunkett, SM Han, ...
Proceedings of the National Academy of Sciences 90 (9), 3988-3992, 1993
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
MC Haffner, MJ Aryee, A Toubaji, DM Esopi, R Albadine, B Gurel, ...
Nature genetics 42 (8), 668-675, 2010
Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis.
YA Lazebnik, S Cole, CA Cooke, WG Nelson, WC Earnshaw
The Journal of cell biology 123 (1), 7-22, 1993
Hypermethylation of CpG islands in primary and metastatic human prostate cancer
S Yegnasubramanian, J Kowalski, ML Gonzalgo, M Zahurak, ...
Cancer research 64 (6), 1975-1986, 2004
Cyclooxygenases in cancer: progress and perspective
S Zha, V Yegnasubramanian, WG Nelson, WB Isaacs, AM De Marzo
Cancer letters 215 (1), 1-20, 2004
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte …
JW Simons, B Mikhak, JF Chang, AM DeMarzo, MA Carducci, M Lim, ...
Cancer research 59 (20), 5160-5168, 1999
Synergistic activation of functional estrogen receptor (ER)-α by DNA methyltransferase and histone deacetylase inhibition in human ER-α-negative breast cancer cells
X Yang, DL Phillips, AT Ferguson, WG Nelson, JG Herman, NE Davidson
Cancer research 61 (19), 7025-7029, 2001
Keratin classes: molecular markers for different types of epithelial differentiation
TT Sun, R Eichner, WG NELsoN, CGS Tseng, RA WEIss, M JARvINEN, ...
Journal of Investigative Dermatology 81 (1), S109-S115, 1983
Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer
JW Simons, EM Jaffee, CE Weber, HI Levitsky, WG Nelson, MA Carducci, ...
Cancer research 57 (8), 1537-1546, 1997
The role of inflammation in the pathogenesis of prostate cancer
WG Nelson, AM De Marzo, TL DeWEESE, WB Isaacs
The Journal of urology 172 (5), S6-S12, 2004
Prostate carcinogenesis and inflammation: emerging insights
GS Palapattu, S Sutcliffe, PJ Bastian, EA Platz, AM De Marzo, WB Isaacs, ...
Carcinogenesis 26 (7), 1170-1181, 2005
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
TL DeWeese, H van der Poel, S Li, B Mikhak, R Drew, M Goemann, ...
Cancer research 61 (20), 7464-7472, 2001
The system can't perform the operation now. Try again later.
Articles 1–20